Biosphere Medical, Inc. - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Biosphere Medical, Inc.. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Biosphere Medical, Inc.. The Group's principal activity is to develop, market and manufacture medical device products for the treatment of hypervascularized tumors and arteriovenous malformations during embolotherapy. Embolotherapy is a procedure in which embolic materials such as microspheres are injected through a catheter into the blood vessels to inhibit blood flow to tumors and arteriovenous malformations. The Group's patented platform technology also has applications in tissue bulking, tissue repair and drug delivery. The products include Embosphere Microspheres, EmboGold Microspheres, Hepasphere SAP Microspheres and TempRx Microspheres. In addition to embolotherapic products, the Group also sells barium delivery kits and other ancillary products in the European Union. Barium kits are purchased from Guerbet Medical Inc and resold for use in gastrointestinal medical testing.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report